Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1033 to 1040 of 1040 entries
Sorted by: Best Match Show Resources per page
Targeting citrullination in autoimmunity: insights learned from preclinical mouse models.

Expert opinion on therapeutic targets

Bruggeman Y, Sodré FMC, Buitinga M, Mathieu C, Overbergh L, Kracht MJL.
PMID: 33896351
Expert Opin Ther Targets. 2021 Apr;25(4):269-281. doi: 10.1080/14728222.2021.1918104. Epub 2021 May 04.

INTRODUCTION: Aberrant citrullination and excessive peptidylarginine deiminase (PAD) activity are detected in numerous challenging autoimmune diseases such as rheumatoid arthritis, inflammatory bowel diseases, systemic lupus erythematosus, multiple sclerosis, and type 1 diabetes. Because excessive PAD activity is a common...

Cite
Bruggeman Y, Sodré FMC, Buitinga M, et al. Targeting citrullination in autoimmunity: insights learned from preclinical mouse models. Expert Opin Ther Targets. 2021;25(4):269-281doi: 10.1080/14728222.2021.1918104.
Bruggeman, Y., Sodré, F. M. C., Buitinga, M., Mathieu, C., Overbergh, L., & Kracht, M. J. L. (2021). Targeting citrullination in autoimmunity: insights learned from preclinical mouse models. Expert opinion on therapeutic targets, 25(4), 269-281. https://doi.org/10.1080/14728222.2021.1918104
Bruggeman, Ylke, et al. "Targeting citrullination in autoimmunity: insights learned from preclinical mouse models." Expert opinion on therapeutic targets vol. 25,4 (2021): 269-281. doi: https://doi.org/10.1080/14728222.2021.1918104
Bruggeman Y, Sodré FMC, Buitinga M, Mathieu C, Overbergh L, Kracht MJL. Targeting citrullination in autoimmunity: insights learned from preclinical mouse models. Expert Opin Ther Targets. 2021 Apr;25(4):269-281. doi: 10.1080/14728222.2021.1918104. Epub 2021 May 04. PMID: 33896351.
Copy Download .nbib Format: NLM
Postural orthostatic tachycardia syndrome after surgical correction of an aortic coarctation: a case report.

Journal of medical case reports

Fernex L, Coeytaux A, Rochat T, Karaca S, Perrig S, Burri H, Nendaz MR.
PMID: 22889291
J Med Case Rep. 2012 Aug 13;6:241. doi: 10.1186/1752-1947-6-241.

INTRODUCTION: We report a case of postural tachycardia syndrome occurring after the surgical correction of an aortic coarctation, and coexisting with upper airway resistance syndrome.CASE PRESENTATION: A 29-year-old Caucasian man complained of extreme fatigue, daytime sleepiness, shortness of breath...

Cite
Fernex L, Coeytaux A, Rochat T, et al. Postural orthostatic tachycardia syndrome after surgical correction of an aortic coarctation: a case report. J Med Case Rep. 2012;6:241doi: 10.1186/1752-1947-6-241.
Fernex, L., Coeytaux, A., Rochat, T., Karaca, S., Perrig, S., Burri, H., & Nendaz, M. R. (2012). Postural orthostatic tachycardia syndrome after surgical correction of an aortic coarctation: a case report. Journal of medical case reports, 6241. https://doi.org/10.1186/1752-1947-6-241
Fernex, Lucie, et al. "Postural orthostatic tachycardia syndrome after surgical correction of an aortic coarctation: a case report." Journal of medical case reports vol. 6 (2012): 241. doi: https://doi.org/10.1186/1752-1947-6-241
Fernex L, Coeytaux A, Rochat T, Karaca S, Perrig S, Burri H, Nendaz MR. Postural orthostatic tachycardia syndrome after surgical correction of an aortic coarctation: a case report. J Med Case Rep. 2012 Aug 13;6:241. doi: 10.1186/1752-1947-6-241. PMID: 22889291; PMCID: PMC3443665.
Copy Download .nbib Format: NLM
Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis.

Arab journal of urology

Moschini M, Zamboni S, Afferi L, Pradere B, Abufaraj M, Soria F, D'Andrea D, Roupret M, De la Taille A, Simeone C, Mattei A, Mathieu R, Bensalah K, Wirth MP, Montorsi F, Briganti A, Gallina A, Simone G, Gallucci M, Di Bona C, Marra G, Mari A, Di Trapani E, Alvarez Maestro M, Krajewski W, Shariat SF, Xylinas E, Baumeister P.
PMID: 33763246
Arab J Urol. 2020 Sep 04;19(1):31-36. doi: 10.1080/2090598X.2020.1817720.

OBJECTIVES: To compare oncological outcomes of open (ORNU) and laparoscopic radical nephroureterectomy (LRNU) after controlling for preoperative patient-derived factors.PATIENTS AND METHODS: We evaluated a multi-institutional collaborative database composed of 3984 patients diagnosed with upper tract urothelial carcinoma (UTUC) treated...

Cite
Moschini M, Zamboni S, Afferi L, et al. Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis. Arab J Urol. 2020;19(1):31-36doi: 10.1080/2090598X.2020.1817720.
Moschini, M., Zamboni, S., Afferi, L., Pradere, B., Abufaraj, M., Soria, F., D'Andrea, D., Roupret, M., De la Taille, A., Simeone, C., Mattei, A., Mathieu, R., Bensalah, K., Wirth, M. P., Montorsi, F., Briganti, A., Gallina, A., Simone, G., Gallucci, M., Di Bona, C., Marra, G., Mari, A., Di Trapani, E., Alvarez Maestro, M., Krajewski, W., Shariat, S. F., Xylinas, E., & Baumeister, P. (2020). Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis. Arab journal of urology, 19(1), 31-36. https://doi.org/10.1080/2090598X.2020.1817720
Moschini, Marco, et al. "Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis." Arab journal of urology vol. 19,1 (2020): 31-36. doi: https://doi.org/10.1080/2090598X.2020.1817720
Moschini M, Zamboni S, Afferi L, Pradere B, Abufaraj M, Soria F, D'Andrea D, Roupret M, De la Taille A, Simeone C, Mattei A, Mathieu R, Bensalah K, Wirth MP, Montorsi F, Briganti A, Gallina A, Simone G, Gallucci M, Di Bona C, Marra G, Mari A, Di Trapani E, Alvarez Maestro M, Krajewski W, Shariat SF, Xylinas E, Baumeister P. Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis. Arab J Urol. 2020 Sep 04;19(1):31-36. doi: 10.1080/2090598X.2020.1817720. PMID: 33763246; PMCID: PMC7954493.
Copy Download .nbib Format: NLM
KRAS G12C fragment screening renders new binding pockets.

Small GTPases

Mathieu M, Steier V, Fassy F, Delorme C, Papin D, Genet B, Duffieux F, Bertrand T, Delarbre L, Le-Borgne H, Parent A, Didier P, Marquette JP, Lowinski M, Houtmann J, Lamberton A, Debussche L, Alexey R.
PMID: 34558391
Small GTPases. 2022 Jan;13(1):225-238. doi: 10.1080/21541248.2021.1979360. Epub 2021 Sep 24.

KRAS genes belong to the most frequently mutated family of oncogenes in cancer. The G12C mutation, found in a third of lung, half of colorectal and pancreatic cancer cases, is believed to be responsible for a substantial number of...

Cite
Mathieu M, Steier V, Fassy F, et al. KRAS G12C fragment screening renders new binding pockets. Small GTPases. 2021;13(1):225-238doi: 10.1080/21541248.2021.1979360.
Mathieu, M., Steier, V., Fassy, F., Delorme, C., Papin, D., Genet, B., Duffieux, F., Bertrand, T., Delarbre, L., Le-Borgne, H., Parent, A., Didier, P., Marquette, J. P., Lowinski, M., Houtmann, J., Lamberton, A., Debussche, L., & Alexey, R. (2022). KRAS G12C fragment screening renders new binding pockets. Small GTPases, 13(1), 225-238. https://doi.org/10.1080/21541248.2021.1979360
Mathieu, Magali, et al. "KRAS G12C fragment screening renders new binding pockets." Small GTPases vol. 13,1 (2022): 225-238. doi: https://doi.org/10.1080/21541248.2021.1979360
Mathieu M, Steier V, Fassy F, Delorme C, Papin D, Genet B, Duffieux F, Bertrand T, Delarbre L, Le-Borgne H, Parent A, Didier P, Marquette JP, Lowinski M, Houtmann J, Lamberton A, Debussche L, Alexey R. KRAS G12C fragment screening renders new binding pockets. Small GTPases. 2022 Jan;13(1):225-238. doi: 10.1080/21541248.2021.1979360. Epub 2021 Sep 24. PMID: 34558391.
Copy Download .nbib Format: NLM
Overview of the Development and Use of Akt Inhibitors in Prostate Cancer.

Journal of clinical medicine

Gasmi A, Roubaud G, Dariane C, Barret E, Beauval JB, Brureau L, Créhange G, Fiard G, Fromont G, Gauthé M, Ruffion A, Renard-Penna R, Sargos P, Rouprêt M, Ploussard G, Mathieu R.
PMID: 35011901
J Clin Med. 2021 Dec 29;11(1). doi: 10.3390/jcm11010160.

Deregulation of the PI3K-Akt-mTOR pathway plays a critical role in the development and progression of many cancers. In prostate cancer, evidence suggests that it is mainly driven by PTEN loss of function. For many years, the development of selective...

Cite
Gasmi A, Roubaud G, Dariane C, et al. Overview of the Development and Use of Akt Inhibitors in Prostate Cancer. J Clin Med. 2021;11(1)doi: 10.3390/jcm11010160.
Gasmi, A., Roubaud, G., Dariane, C., Barret, E., Beauval, J. B., Brureau, L., Créhange, G., Fiard, G., Fromont, G., Gauthé, M., Ruffion, A., Renard-Penna, R., Sargos, P., Rouprêt, M., Ploussard, G., & Mathieu, R. (2021). Overview of the Development and Use of Akt Inhibitors in Prostate Cancer. Journal of clinical medicine, 11(1), . https://doi.org/10.3390/jcm11010160
Gasmi, Anis, et al. "Overview of the Development and Use of Akt Inhibitors in Prostate Cancer." Journal of clinical medicine vol. 11,1 (2021). doi: https://doi.org/10.3390/jcm11010160
Gasmi A, Roubaud G, Dariane C, Barret E, Beauval JB, Brureau L, Créhange G, Fiard G, Fromont G, Gauthé M, Ruffion A, Renard-Penna R, Sargos P, Rouprêt M, Ploussard G, Mathieu R. Overview of the Development and Use of Akt Inhibitors in Prostate Cancer. J Clin Med. 2021 Dec 29;11(1). doi: 10.3390/jcm11010160. PMID: 35011901; PMCID: PMC8745410.
Copy Download .nbib Format: NLM
Reprotech in France and the United States: Differences and similarities - An introduction.

Reproductive biomedicine & society online

Mathieu S, Rapp R.
PMID: 33817356
Reprod Biomed Soc Online. 2021 Feb 19;11:106-109. doi: 10.1016/j.rbms.2021.02.001. eCollection 2020 Nov.

No abstract available.

Cite
Mathieu S, Rapp R. Reprotech in France and the United States: Differences and similarities - An introduction. Reprod Biomed Soc Online. 2021;11:106-109doi: 10.1016/j.rbms.2021.02.001.
Mathieu, S., & Rapp, R. (2020). Reprotech in France and the United States: Differences and similarities - An introduction. Reproductive biomedicine & society online, 11106-109. https://doi.org/10.1016/j.rbms.2021.02.001
Mathieu, Séverine, and Rapp, Rayna. "Reprotech in France and the United States: Differences and similarities - An introduction." Reproductive biomedicine & society online vol. 11 (2020): 106-109. doi: https://doi.org/10.1016/j.rbms.2021.02.001
Mathieu S, Rapp R. Reprotech in France and the United States: Differences and similarities - An introduction. Reprod Biomed Soc Online. 2021 Feb 19;11:106-109. doi: 10.1016/j.rbms.2021.02.001. eCollection 2020 Nov. PMID: 33817356; PMCID: PMC8010351.
Copy Download .nbib Format: NLM
Integrating Research, Teaching and Learning: Preparing the Future National STEM Faculty.

Pfund C, Hooper EJ, Mathieu R.
UIID-AD: 471
2010;431:411-415.

A network of universities (Howard, Michigan State, Texas A&M, University of Colorado at Boulder, University of Wisconsin-Madison, Vanderbilt) have created a National Science Foundation-funded network to prepare a future national STEM (science, technology, engineering, mathematics) faculty committed to learning,...

Cite
Pfund C, Hooper EJ, Mathieu R. Integrating Research, Teaching and Learning: Preparing the Future National STEM Faculty. 2010;431:411-415
Pfund, C., Hooper, E. J., & Mathieu, R. (2010). Integrating Research, Teaching and Learning: Preparing the Future National STEM Faculty. 431411-415.
Pfund, C, et al. "Integrating Research, Teaching and Learning: Preparing the Future National STEM Faculty." vol. 431 (2010): 411-415.
Pfund C, Hooper EJ, Mathieu R. Integrating Research, Teaching and Learning: Preparing the Future National STEM Faculty. 2010;431:411-415. UIID-AD: 471.
Copy Download .nbib Format: NLM
Learning to Become a More Effective Research or Inquiry-based Project Mentor.

Pfund C, Branchaw J, Hooper EJ, Mathieu R.
UIID-AD: 470
2010;431:247-256.

How effective of a mentor are you? Have you thought much about this question? Have you participated in training to become a better mentor? For many academics, the typical three answers are "pretty good, I think ... why wouldn't...

Cite
Pfund C, Branchaw J, Hooper EJ, et al. Learning to Become a More Effective Research or Inquiry-based Project Mentor. 2010;431:247-256
Pfund, C., Branchaw, J., Hooper, E. J., & Mathieu, R. (2010). Learning to Become a More Effective Research or Inquiry-based Project Mentor. 431247-256.
Pfund, C, et al. "Learning to Become a More Effective Research or Inquiry-based Project Mentor." vol. 431 (2010): 247-256.
Pfund C, Branchaw J, Hooper EJ, Mathieu R. Learning to Become a More Effective Research or Inquiry-based Project Mentor. 2010;431:247-256. UIID-AD: 470.
Copy Download .nbib Format: NLM
Showing 1033 to 1040 of 1040 entries